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NAVIGATING THE HEALTH









































All content found in this toolkit, including: text, images, and other formats
were created for informational purposes only. 
This content is not intended to be a substitute for professional legal  or
medical advice, diagnosis, or treatment. 
Always seek the advice of your physician or other qualified health provider
or legal counsel with any questions you may have regarding a medical
condition or legal situation. 
Never disregard professional medical advice or delay in seeking it because
of something you have read in this toolkit.
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Harm Reduction Coalition is a national advocacy and capacity-building organization that works to
promote the health and dignity of individuals and communities who are impacted by drug use --
including pregnant and parenting people.
The Academy of Perinatal Harm Reduction provides evidence-based, inclusive, affirming
education for parents and providers. Our work is informed by lived experience and is focused on
the intersection of substance use and reproductive health.
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Pregnant people and their families
can use this information to understand
their rights, access services, and find
high-quality, evidence-based care.
This toolkit was developed in New York
State, so some of the resources linked
are specific to New York State. 
 
This information is intended for use by
pregnant and parenting people who
use drugs, their loved ones, and their
service providers. 
Our goal is to promote the
overall health and well-being 
of pregnant people who use
substances and their families. 
For many people, upon finding out they
are pregnant, they may wonder about
reducing or stopping their use.  It is
important to know that there are many
steps that can be taken, related to
substance use or not, to have a
healthy pregnancy. 
These materials can be shared with
family members and service providers
in order to start important
conversations about your plans,
hopes, goals, and dreams. You can
download the entire toolkit, or make
your own by downloading sections
individually. 
This work is written, edited, and
informed by people who have lived
experience of substance use and
pregnancy. In this toolkit we use the
term "pregnant people" not
"pregnant women" in order to be
inclusive of people of all genders
who have the capacity to become
pregnant. 
 
We know that you are the experts.
We would love to hear from you. Can
this toolkit be improved? Do you want
to be involved in future work?
 
Please contact us at:
pregnancy@harmreduction.org
 
Pregnant and parenting people who
use substances are one of the most
stigmatized and demonized subsets
of the population. 
Experience with bias, judgment,
and scrutiny - especially from
healthcare workers, loved ones,
family, and friends - can isolate
people and make it harder to seek
prenatal care, mental health
counseling, social services, and
community support.
People don’t like to go to places
where they don’t feel welcomed.
They may fear for their safety, or
the safety of their children, or their
pregnancy. That's why having
even one nonjudgmental and
trustworthy person to support
them can make all the difference









You deserve to have providers and
support people who affirm you and
your gender identity.  People of all
genders can become pregnant and
have healthy birth outcomes. 
Check out these resources for you
and your providers on fertility,
pregnancy, and postpartum support




Unconditional positive regard is useful both in the clinical setting and
in everyday life. And it is an essential tool in harm reduction. 
It appreciates that people make choices based on their unique needs,
experiences, and circumstances. It acknowledges that everyone is
different; what is right for one person may not be right for another. 
When people are trusted to make their own decisions and are
treated with dignity and respect, they are more likely to be honest.
People will know that they will be able to get the support they need,
regardless of the choices they have made. 
You respect their right to make important decisions about their body
and their health. 
WHY IT MATTERS
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Unconditional positive regard can be a
great tool for boosting people's self-esteem
and showing them you believe that they can
be good parents.
The concept of unconditional positive regard
assumes that people are inherently good. 
POSITIVE REGARD
It means that when you talk to someone you address the whole person,
instead of just focusing on their substance use.
When you have unconditional positive regard for someone:
You believe that they are competent and capable of choosing what is
right for them based on their unique circumstances. 
www.per inatalharmreduct ion.org
Motivational Interviewing (MI) is a tool that can help you navigate tough
conversations. Providers can take classes in this technique in order to have
better conversations about behavior change. With a little practice, this is a
technique that can be easily used by anyone.
When providers use MI techniques they should ask questions and listen to
the answers. Instead of giving directions or making accusations, they focus
on identifying your goals and listening with compassion. 
MI recognizes that it takes time to build trust and that you might wait to









If you loved your
children you'd
stop using.
         I know you love
your children. What can
we do to help you












Instead of saying... Say...
Instead of saying... Say...
         What was






Many of the words used to describe drugs and people who use them are
stigmatizing. It is everyone's responsibility to try to avoid judgmental
language.  Using “person-first” language demonstrates that you value the
person, and are not defining them by their drug use.
When talking about your own substance use, you can choose the language
that feels right to you. But you should never use stigmatizing terms when
you talk about others because these words shape our beliefs. Words can
signal whether or not you value and respect people who use drugs and the
people who care for them.
Adjusting to “person-first” language can be awkward at first, but it is worth
it because it helps us better serve and support people who are often
subjected to shaming and stigmatizing language.
www.harmreduct ion.org














Can we talk about. . .
What do you think about. . .
Would you want to. . .
We know that. . .
Some of the choices are. . .
You might want to. . .
You know what you.. .
You want to,  but. . .
So your plan is. . .
5
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Don't Use Do Use Why
BEST PRACTICES TO AVOID USING








that you value the person,
and are not defining them
by their drug use.
“person with cocaine
use disorder” 
“got clean” “not currently using
drugs”
”Clean,” implies that
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Widespread stigma creates
significant barriers to
accessing what people need
to survive and thrive, such as
care, housing, income and
social services.
Internalized stigma is when people
believe the negative messages from
the outside world. Internalized stigma
means that sometimes you might feel
ashamed of yourself based on your
substance use.
When people who use drugs accept
and internalize this stigma, it can
lead to anxiety, isolation, and loss
of self-love.    If someone is told
enough times that they are worthless,
it can influence how they make
decisions about their health and
safety. Because of this, people may
accept injustice because they
believe they deserve to suffer. 
When people can’t tell anyone what
they use, when they use, and where
they use, they are more likely to use
alone, increasing their risk of
overdose. 
BeSafe App
Never Use Alone      
(800)484-3731
stigma from individuals
someone using the word “junkie”
institutional stigma firing people
based on a positive drug screen
stigma through association
when pharmacists or medical
providers say,“That’s not the
population I want in my office”
internalized stigma believing
you deserve pain or suffering
because you use drugs 
Stigma is a process that
discriminates against people who
use drugs and pushes them to the
margins of society. There are
several forms of stigma, such as:
 
Stigma toward people who use
drugs is written into our laws,
child protective service and
social service systems. Despite
widespread acceptance that
substance use is a health condition
and not a personal character flaw,
stigma against people who use










Part of respectful healthcare is
trauma-informed care. Trauma-
informed care is healthcare that
recognizes the impact of negative
life experiences such as
incarceration, unhealthy intimate
relationships, loss of loved ones, as
well as emotional, verbal, and
sexual abuse. 
Stigma is amplified if a person
who uses drugs becomes
pregnant.    They may become
isolated even from people who knew
about and accepted their substance
use before pregnancy. 
It is important that you and your
support system build up your self-
esteem and hope for your future.
You have many positive qualities
and deserve to be your best self.
You deserve to be treated with
dignity and respect, as someone
capable of making the best choices
for yourself. 
You deserve to be surrounded with
people that help you identify, grow,
and celebrate your strengths.
You deserve to talk with people not
only about how to work on problem
areas, but how to imagine and plan
for a happy future. 
Talk with them about accessing
healthcare and what your hopes and
concerns are. Talk with them about
medications for opioid use disorder
as well as whether you envision
having a family now or in the
future.  
Ask your care providers to
become familiar with
"trauma-informed care." 












Understand that it is not necessary for someone to disclose the
specifics of their trauma in order to receive trauma-informed care.
Display positive and welcoming signage and set a friendly tone when
people access services, with an integrated and consistent response from
all team members, from front desk staff to direct care workers.
Establish a comforting and welcoming physical environment.
Use strength-based, person-first language. 
Recognize behaviors that providers interpret as being difficult (such as
being rude, asking too many questions, or expressing frustration) as
attempts to deal with negative past experiences or current stressors.
Recognize that some people will need more support and different types
of support than others.
If you are a service provider, evaluate yourself and recognize what you
bring to the interaction - your own story, family experiences, race,
religion, beliefs about substance use and pregnancy, and triggers.
Learn how to effectively engage in therapeutic conversations with
people, including opening conversations, de-escalating when people are
getting upset, helping clients in constructively interacting with healthcare
providers who are not trauma-informed.
Give choices to participants and clients that empower them to set
boundaries and determine the pace of physical assessments in the clinical
setting.
Some basic strategies to begin providing trauma-informed care across the
perinatal and postpartum continuum are: 
www.harmreduct ion.org
TRAUMA-INFORMED CARE  
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CONSIDER BRINGING THIS TOOLKIT TO YOUR PROVIDER 
www.per inatalharmreduct ion.org
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When Intervention or Action













Support clients to access organizations that can address
immediate practical needs such as safe housing, food,
clothing, medical concerns, leaving violent relationships, and  
transportation.
Develop approaches to providing prenatal services that are
integrated and coordinated across health and social systems,
including child welfare.
Consider the impact of sexual abuse and trauma on
childbirth. Clients can also experience traumatic childbirth if
they feel disrespected or shamed during this time.  Black,
Indigenous, and other people of color experience higher
rates of disrespect and mistreatment in birth.
Support immediate attachment between parent and baby.
People with histories of substance use, mental health issues,
trauma and violence may have a more difficult time bonding.
Keep families together as much as possible during hospital
stay, including combined parent-baby care/rooming-in
models, promoting early frequent skin-to-skin for bonding and
other parent-baby neuropsychological benefits. 
Consider the relationship between trauma and
breast/chestfeeding (some people refer to mammary tissue
as their chest rather than their breast). The physical contact
of breast/chestfeeding can be uncomfortable for some
trauma survivors and trans people. There are a number of
strategies to address this issue. 
Include a focus on parent-child relationships in all
interventions. Clients with a history of abuse or trauma have
a higher likelihood of not bonding well. However, they are
able to increase attachment over time.
Assess for postpartum depression and other mood disorders.
Women and childbearing people with a history of trauma are












Deciding whether to carry a pregnancy to term and deliver a baby is a very
personal decision. For some people, the decision is easy, and for some people
it can be difficult. People can have a wide variety of emotions when they find
out that they are pregnant, but know that being on medication for opioid use
disorder, or using drugs, should not be a reason you decide to have an
abortion. Though we don't often talk about it, miscarriage and pregnancy loss
are common experiences.  10-20% of all pregnancies end in miscarriage, so it
is important that pregnancy loss should not be blamed on substance use. 
For many, the realization that they're pregnant can be surprising and
overwhelming. It's normal to have conflicting emotions. For example, you might
be scared and excited at the same time. Some people find it helpful to talk to
their partners, friends and family - but only you can make this personal
decision. There are also free resources to help you talk through this decision
non-judgmentally, such as All Options.      (888) 493-0092
www.harmreduct ion.org
TO BIRTH OR NOT TO BIRTH  
Your healthcare providers should never pressure you
 to continue or end a pregnancy.
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CONTINUING A PREGNANCY
If you choose to continue your pregnancy,
the next steps are to:
Identify your support system.
Find a prenatal care provider (see page 14). 
For more information, see
Section 4: Prenatal Care
It is important to remember that using
substances before you realized you were
pregnant or during your pregnancy does not
mean that your baby will be harmed. 
For more information, see
Section 2: Harm Reduction 
15
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If you decide to have an abortion you should contact a healthcare
provider that you trust.  There are also online resources for locating
abortion providers in your area. If you cannot afford an abortion or
travel to a clinic, most clinics have connections to organizations that can
help cover these costs. For more information on resources in your area
see the National Network of Abortion Funds
Of course, because both drug use and abortion are stigmatized,
providers may mistreat you or refuse to care for you. Remember that
you deserve to be treated with dignity and respect.
ENDING A PREGNANCY
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Abortion Pill from Planned
Parenthood
Plan C:
A Safe Abortion with Pills
MEDICATION ABORTION PROCEDURAL ABORTION 
www.harmreduct ion.org
A medication abortion happens
when you take medications that
prevent a pregnancy from growing
and cause your uterus to empty.
This induces a process similar to
a miscarriage. 
Some clinics will prescribe you
these medications and permit you
to take them at home. Other
clinics may have you take the first
medication in the clinic and the
second can be taken at home.
Ibuprofen is recommended for pain
control, and is generally safe to
take with other substances or
medications you may take.  
A healthcare provider can
perform a simple procedure
that removes a pregnancy from
your uterus. 
This procedure must be done
in a clinic or hospital.
There are many options for
pain control including local
anesthesia (numbing the area
with lidocaine), minimal/
moderate sedation (usually
an opioid and benzodiazepine
administered by IV) and deep
sedation (IV medications




Family Planning Benefit Program
Abortion Care Policies in New York
Abortion Care Network
National Abortion Federation
increase the dose of opioids they give
during the procedure to help with
discomfort.
Some abortion providers are not
comfortable with managing pain in
patients who take buprenorphine, so you
can ask them to reach out to your
buprenorphine provider for information if
that feels safe to you.  Many abortion
providers would be willing to be vague
about the type of procedure you will be
having if you suggest language like
"they are at my facility today for a minor
procedure for which we'd like to offer
minimal sedation..."
If you have any concerns about urine
drug screens at your buprenorphine or
methadone provider's office, feel free to
ask your abortion provider for a note
about the medications you were
administered or prescribed. Again, most
abortion providers are willing to be
vague about the type of procedure you
had if you would like your buprenorphine
or methadone provider to not know
about your abortion.
For medication abortions, people will
experience bleeding, and may have
intense cramping and gastrointestinal
discomfort (vomiting and diarrhea).
For procedural abortions, most
people who are awake for the
procedure describe the discomfort as
intense period cramps. In most cases,
the procedure lasts less than five
minutes.  
Since pain can be made more intense by
certain emotions or nervousness,
consider having a plan for breathing
exercises, bringing calming music to
listen to, or using pressure points.  
If you take a medication for opioid
use disorder, you may not receive
accurate information about pain
control or adequate pain control. If
you are taking buprenorphine
(Suboxone) or methadone, take your
regular dose.  If you are considering
mild or deep sedation and feel safe
enough to tell the team of folks
performing your abortion about your
medications, they may be able to 
Reproductive Health Access Project 
www.harmreduct ion.org
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NEW YORK STATE:RELIABLE PROVIDERS:
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A doula is a support person who can be with you during pregnancy, birth,
termination, or the postpartum period (also called the 4th trimester). They can
be licensed or unlicensed. Doulas advocate for you, help you make
decisions, and provide general support. Some provide their services at low to
no-cost. 
Doulas will typically meet with you once or twice during your pregnancy to
develop a relationship with you and your support people. During pregnancy, a
doula can help you learn about your options and help you make plans for
child birth and early parenting. During labor and birth, it is their job to care
for you and advocate for you in a non-judgmental, non-medical way, especially
during stressful situations. 
When searching for a doula, get as much information about them as possible.
Ask them if they provide trauma-informed care or have experience with
people who use drugs. If you have relationships with trusted social service
providers, community health care workers, case managers, or substance use
treatment providers you may ask them to help you find an experienced doula.
THE ROLE OF DOULAS  
New York State Doula Pilot Program - Medicaid
PREGNANCY PROVIDERS
Family Medicine Physicians and Primary Care Providers
offer comprehensive health care services for people of all ages.
They also provide care for low-risk pregnancies and births. 
Obstetrics and Gynecology Nurse Practitioners (NPs or OGNPs) have special
training in providing reproductive and pregnancy health care.
Obstetrician/Gynecologists (OB/GYNs) provide comprehensive
reproductive health care, whether someone is pregnant or not. 
Midwives provide sexual and reproductive health care. Midwives generally
care for healthy, low-risk pregnancies but they can consult with specialists if
there are any problems. Certified Nurse Midwives (CNMs) are licensed to
provide care everywhere in the country and Certified Professional Midwives
(CPMs) are licensed in 36 states.  There are other types of midwives who are
not required to be licensed, but their services may not be covered in your state
or by your insurance. Check with your provider.
Maternal-Fetal Medicine Specialists (MFMs), also called Perinatologists,





Harm reduction is a radical change
from the way society has historically
responded to substance use. 
Harm reduction is the idea that
since we cannot completely
eliminate risk and harm, we should
do our best to minimize them.
Most of the problems our society links
with drug use are not caused by use.
For example, disease, crime, and
violence are not actually related to
substances themselves, but to
structural racism and criminalization. 
Some examples of risk reduction in our
daily lives are wearing seatbelts, using
condoms, and getting enough sleep.
SECTION 2
our words and actions that we
respect and love people who use
drugs.
Abstaining from all recreational
substance use during pregnancy
and breast/chestfeeding is the
safest option. It is important to
understand that some people have
trouble achieving abstinence, or
simply don’t want to. Those that want
to stop or cut down but cannot may
have a substance use disorder.
 
Whether or not you're using,
your health and pregnancy
matter!
Substance use is just one of many
things that influence health and
pregnancy outcomes. This section 
15
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The most important and radical part of
harm reduction is to demonstrate with 
will give you the tools you need to be as healthy as possible, whether or not
you're using.  
Most people try several times before they can stop using. A good
healthcare provider will continue to work with people who are unable or
unwilling to stop using, rather than dropping them as clients. Multiple
lapses are an expected part of just about everyone’s journey. If a treatment
does not work, try something else. Remember: the treatment failed, not you.
Much of the research that has been conducted on pregnant people who use
drugs cannot definitively state if one behavior or drug causes a bad
outcome. In many cases, studies about pregnancy and substance use
cannot control for other variables (such as poverty, racism, other substance
use, trauma, and poor nutrition) that might lead to negative outcomes. 
This informat ion wi l l  be organized by substance. Each substance wi l l  l is t
the most severe possible harms f i rst ,  which can be rare,  and then more
common ones. Stopping alcohol  or  benzodiazepine use abrupt ly wi thout
the assistance of  a medical  professional  can be dangerous.  Be sure to
speak with a provider i f  you’re consider ing this act ion.  Another potent ia l
danger is that  street-based drug markets are unregulated.  Products are
mixed with f i l lers and other drugs, so you may not be consuming what you
think you are.
TIPS FOR A HEALTHY PREGNANCY 
Prenatal  v i tamins provide you with the extra minerals and
nutr ients you need to protect  your heal th and ensure your
baby's heal thy development.
This is the most important th ing you can do. Gett ing care
ear ly and of ten reduces your r isks for  most compl icat ions.  
Focus on staying hydrated, gett ing enough sleep,
and eat ing wel l  to help you have a heal thy
pregnancy.
HARM REDUCTION + PREGNANCY
TAKE YOUR VITAMINS 
GET GOOD PRENATAL CARE 
SUPPORT YOUR BODY
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Set personal limits of how
often and how much you use. 
For example, you won't use
more than 2 bags of heroin
every 8 hours. 





are alone, if possible.   
HARM REDUCTION + PARENTING 
www.harmreduct ion.org
Keep track of how
much you use. This
may reduce your
use, even if that was
not your original
goal.
Set limits on when
and where you use,
like waiting until after
5:00 to drink.
Make a list of the
pros and cons of
stopping and
continuing to use.









Make a parenting plan.
Before any substance
use - including alcohol
use - arrange for
childcare if necessary.
Take good care of
your body in general,
like eating healthy and
getting enough sleep,
exercise, and water.
Switch to a safer method.
See Getting Off Right
Safety Manual.
17
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Many people try to cut down or stop
drinking alcohol during pregnancy.
Stopping alcohol abruptly (going
“cold turkey”) can be dangerous and
can cause seizures, and in rare
cases, even death. If you are trying
to decrease your alcohol
consumption, discuss this with a
provider, especially if you have had
seizures before.
Drinking alcohol while pregnant
increases the chance of miscarriage
or stillbirth.  Drinking alcohol while
pregnant can also cause birth
defects, called Fetal Alcohol
Spectrum Disorder (FASD). FASD
can include organ defects,
limitations in thinking, reasoning and
learning as well as physical effects
such as abnormal facial features,
low birth weight, and smaller head
size.
  
No one knows exactly how much
alcohol is safe to drink during
pregnancy and it is probably
different for each person.  
Not every person who consumes
alcohol during pregnancy will give
birth to a child with symptoms of
Fetal Alcohol Spectrum Disorder.
Long-term outcome studies of
children with alcohol exposure
suggest that binge drinking or
severe alcohol use disorder could
be associated with an increase in
the child’s behavior problems or
difficulty thinking (cognition)
especially for children born with
FASD. Studies of low to moderate
alcohol consumption have not found
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Alcohol passes into human milk and is
absorbed by babies if they drink the
milk.    If you have plans that may
include alcohol consumption, pump
and store enough milk before
drinking alcohol. If unable to do
this, use formula. While intoxicated,
if your breasts/chest become painful,
pump or hand express enough milk to
relieve the pressure, then discard it. 
Recommendations for the time it takes
for your milk to be safe for the baby
range from 2-4 hours per drink. 
If you are only going to have one
standard drink, it is okay to feed the
baby, have a drink, wait a few hours,
and feed the baby again without doing
anything special.  
If you still feel drunk or hungover,
even if the recommended time has
passed, wait until you feel better
before providing milk to the baby.
If you want to be 100% sure there
is no alcohol present in the milk,
alcohol test strips for human
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There are many approaches to treatment for people who want to change their
drinking or stop drinking completely. A few common ways are: 
Sometimes, 12 Step groups can be unwelcoming and shaming towards pregnant
people or people using medication for opioid use disorder, so it’s important to
find a group or a method that is supportive of your needs.  
The medications available for the treatment of alcohol dependence are
naltrexone tablets or injections (Vivitrol®), acamprosate (Campral®), disulfiram
(Antabuse®) and gabapentin (Neurontin®). We don’t have good information on
how safe these medications are during pregnancy, but some of them are likely to
be much safer than continuing to drink. Acamprosate is likely safe, as is
naltrexone (though not recommended for opioid use disorder in pregnancy at this
time), while disulfiram is not recommended.  Consult with a provider before
taking any of these medications while pregnant. 
In some cases alcohol dependency and withdrawal 
are associated with serious complications such as seizures.
If you are alcohol-dependent and are trying to decrease 
your alcohol consumption, don't quit "cold turkey." 
Work with a medical provider, especially if you have had
seizures before.
In rare cases, alcohol detox can lead to death. 
Ask for help.
ALCOHOL 
What treatment options are available for people with alcohol
use disorder who are pregnant?
attending 12 Step meetings such as                                             or other
free community meetings like                                      ,                           ,
or                                                       . 
group therapy and individual counseling
medications to treat alcohol use disorder 
Alcoholics Anonymous (AA)
Moderation Management SMART Recovery





Benzodiazepines are a class of
medications prescribed for sleep,
anxiety, and seizures. Some common




Benzodiazepines work in a similar
way to alcohol in the brain on the
same brain receptor. 
If you take benzodiazepines regularly
it can cause tolerance, dependence,
and, if you cut down or stop your use
abruptly, withdrawal symptoms.
Similar to alcohol, detox or cutting
back on benzodiazepines could be
very harmful, as some people
experience withdrawal seizures that
could be deadly.  It is important to
talk to a provider if you want to cut










Benzodiazepine use might slightly
increase the risk of having a baby
with cleft lip or palate, but there is
no link to other birth defects. Some
studies found an increased risk of
lower birth weight and other studies
did not. 
Possible lower birth weights among
people who take these medications
could be related to sleep issues, and
not the medications, because many
people take benzodiazepines for
sleep problems.  
Newborns exposed during pregnancy
can show withdrawal symptoms after
they are born; benzodiazepine use
could worsen withdrawal from other
substances.   
If you are breast/chestfeeding it is important
to take as low a dose of benzodiazepines
as possible while still getting the benefits
you need. Talk to your provider about the
dose that is right for you. 
Not all benzodiazepines are the same in
regard to their safety and lactation. For
example, lorazepam is safer than diazepam.
See LactMed.
In small studies, some breast/chestfed
babies had low muscle tone, sedation, or
difficulties breathing and feeding that
resolved.   A problem with small studies is
that because they include fewer people
their findings are difficult to generalize. 
BENZODIAZEPINES 
+ LACTATION
There are no FDA-approved medications for
benzodiazepine dependence, however, doctors can
prescribe medications that can ease uncomfortable
symptoms. 
If you are using them to help with anxiety, depression, or
insomnia there may be medications that are safer to
use while pregnant or lactating. Seek medical advice. 
Stopping use without help can be dangerous because of
withdrawal symptoms such as seizures. It’s important to
decrease the dose gradually (taper off) with the help
of a healthcare provider rather than stop abruptly. 
BENZODIAZEPINES







Cannabis is a plant that can be
smoked, vaped, eaten, applied
topically on the skin, or ingested in
other forms such as tinctures. 
In some states medical cannabis is
used to relieve symptoms related to
glaucoma, cancer, HIV/AIDS, post-
traumatic stress disorder, chronic
pain and anxiety, and many other
conditions. Some of the other names
for cannabis are marijuana, weed,
herb, mota, and hash. Some other
forms are wax, dabs, oils, tinctures,
and shatter.
Much of the information about effects
of exposure on the fetus is conflicting
and unclear, even to medical
professionals.  Unfortunately the 
l iterature is inconsistent in their
findings.       Long-term outcomes
appear similar to other children in
the same peer group.  
There is no evidence to suggest
that cannabis is related to stillbirth,
preterm labor, significantly low birth
weight, birth defects, or feeding
problems.   There is some recent
evidence (2019) that shows that
cannabis users had higher rates of
preterm birth than nonusers (12.0%
compared to 6.1%), but like most
studies on pregnancy and cannabis,
it was unable to control for many
other factors, including smoking








New research alert: Torres et al. (2020) conducted a systematic review of prenatal
cannabis exposure on cognitive functioning, finding that children with cannabis-exposure
predominantly fell within the normal range, refuting many significant misunderstandings
about cannabis and cognitive functioning. 10
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5, 15, 17, 18
19, 89
Many people who continue to use cannabis during
pregnancy - including those who use it daily - might
have a cannabis use disorder which might make it
more difficult for them to stop.  
Most people who want to quit cannabis do so
without formal treatment, but others have found
counseling or group therapy helpful. 
There is no FDA-approved medication specifically for
cannabis use disorders or dependence. 
If you are using cannabis to medicate for pain, anxiety or
nausea, discuss with your healthcare provider whether
there is a safer treatment method.
CANNABIS
CANNABIS + LACTATION




A 2018 study of eight parents in Colorado
who were exclusively breast/chestfeeding
and smoking cannabis showed that
cannabis does enter the milk supply,
estimating it to be at 2.5% of what the
parent had smoked; dosage peaked at 1
hour after smoking and decreased by 4
hours after consumption.
Formal guidelines recommend that the
safest choice is to stop recreational use
completely while lactating.
If you continue using while breast/chestfeeding, consider using harm reduction
methods like pumping before using or pumping and dumping right after using.
It’s important to remember that even though there are risks from smoking and
breast/chestfeeding, it is still considered better to breast/chestfeed and smoke
than to formula feed and smoke.
OPIOIDS
It is not recommended to detox (or
undergo medically supervised
withdrawal) during pregnancy because
the chances of returning to opioid use
are much higher (up to 59 to 90%).
The risk of overdosing is much
higher after detoxing because of
loss of tolerance.  You can talk to
your provider about medications
www.harmreduct ion.org















such as methadone or
buprenorphine, which are the safest
medications to use for opioid use
disorder (OUD) in pregnancy.
Untreated opioid use disorder has
associations with increased
pregnancy risks such as placental
abruption, preterm labor, fetal death
or overdose in the parent resulting
in possible death.   Some studies
find normal birth weights, and some
find weights in the lower end of
normal.
Long-term outcomes are similar to
other children in the same peer
group if there were no birth
complications.     Opioid use
(including heroin) in pregnancy is






If you are continuing to use, and/or are injecting opioids or
other substances (meth, cocaine, etc.), please do not share
your supplies, wash your hands with soap and water, and 
clean the site before every injection with an alcohol pad. 
Rates of skin and soft tissue infections, blood-borne
bacteria - which can lead to infection of the heart valves
(endocarditis)- are rising among people who inject drugs and
sterile hygiene can prevent many of these infections. 
See Getting Off Right: A Safety Manual for Injection Drug Users
 
For the fetus, the risks of using opioids during pregnancy are largely
related to the baby experiencing neonatal abstinence syndrome (NAS)
or neonatal opioid withdrawal (NOW), which are easily treatable. NAS
has many signs and symptoms that can be assessed in the hospital (many
hospitals use a scoring system). Some of these signs and symptoms include:
irritability, tremors, jitteriness, sleep/wake disturbances, sweating, sneezing,
yawning, nasal congestion, overstimulation, difficulty feeding, poor weight
gain, gassiness, vomiting, and diarrhea.    
This can occur within 24 hours to five days after birth and is related to
physiological withdrawal from any opioid (heroin, fentanyl or treatments like
buprenorphine and methadone). It is treatable with skin-to-skin contact,
keeping the parent in the same hospital room as the infant,
breast/chestfeeding, or also with medications such as methadone,
morphine, buprenorphine or other agents as needed. 
OPIOIDS 26
NEONATAL ABSTINENCE SYNDROME (NAS)
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It is safe to breast/chestfeed while taking medications for
opioid use disorder such as methadone and buprenorphine,
regardless of the dose of medication that you take.  
In fact, breast/chestfeeding can make the baby’s withdrawal
symptoms less severe. Studies suggest this is because skin-
to-skin contact and attachment formation help the baby feel
better while breast/chestfeeding.
When other opioids like methadone were studied, it was found that only about
2% of the total dose made it into human milk.   For buprenorphine, there are
negligible amounts of buprenorphine/norbuprenorphine in human milk and
infants absorb even less of this because of the way buprenorphine is broken
down and metabolized (not absorbed well in the stomach). 
With heroin and other unregulated opioids, it is best not to breast/chestfeed,
since you can’t know the exact dose and it may be cut with other unknown
substances and contaminants that aren’t safe for the baby. 
MotherToBaby 
Drugs and Lactation Database (LactMed)





If you are looking for reliable information on
medications and evidence-based guidance for their
use during pregnancy and lactation, we recommend
these resources:
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Consult the LactMed database to learn more about the





Medication-assisted Treatment from the New York Office of
Addiction Services and Supports
During pregnancy, the body goes through changes that can make drugs and
medications work differently. This means drugs may feel more or less strong than
they used to. For example, many people need to adjust their methadone or
buprenorphine dose during pregnancy because they start to experience withdrawal
symptoms or feel overly-sedated. Report any withdrawal, cravings, or changes in sleep
patterns to your doctor. You might need to split your dose of medication into twice
a day or three times a day instead of once a day. 
There is not enough evidence to know if naltrexone (Revia®, Vivitrol®) is safe to
use during pregnancy, so it is not recommended (unless it is the only thing that is
working for you). An expert panel convened on this issue “did not agree on whether
women [people] on naltrexone should continue to use it during pregnancy. Women
[People] stable on naltrexone can be offered treatment with buprenorphine or
methadone to prevent return to substance use if they choose to discontinue naltrexone
injections. However, this transition must be carefully managed...”  
WHAT TREATMENT OPTIONS ARE AVAILABLE FOR
OPIOID USE DISORDER DURING PREGNANCY?
In New York State according to the law, you have priority
access to treatment if you are pregnant. This means that you













Treatment for opioid use disorder with methadone,
buprenorphine (Subutex®), or a buprenorphine-
naloxone (Suboxone®) combination medication is
safe for pregnancy and lactation and is the best
treatment for pregnant people.
Buprenorphine and methadone initiation during
pregnancy can vary by state and region. Some
healthcare providers might require you to go
inpatient to get monitoring on the OB-GYN floor
and others might feel comfortable with you doing





Medications for Opioid Use Disorder (MOUD), such as
methadone and buprenorphine, should be offered as a
first-line treatment for opioid use disorder.
Detoxing and stopping MOUD, even for a short time, can lower your tolerance
and make it easier to overdose on even a small amount of opioids.         If
you want to detox or decrease your dose of medication, make sure you have
a careful discussion of the risks and benefits with a provider you trust.
However if you must detox, it can be safe for you and your fetus if
appropriately and compassionately done.  Do not attempt detoxification at
home or alone.
 
No one should ever be pressured or coerced into detox,





SET YOUR GOALS TOGETHER
FIND A PROVIDER 




You might have heard that it is not safe to detox during pregnancy because
the distress on the parent puts distress on the fetus, leading to possible
negative outcomes (fetal death or preterm delivery). However, this has not
been found in more recent short-term studies.   Instead, the concern is that
many people relapse and have a decreased tolerance, which could be
dangerous to the parent, fetus or newborn due to risk of overdose/death.   
   
  
New York State's Opioid Overdose
Prevention Program Directories
Find a Pharmacy near you!
NASEN Syringe Exchange
Program Map
Anyone who uses opioids is at risk for opioid overdose. 
This is especially true during and immediately after pregnancy
because of the changes that happen to your body. Changes in your
weight, body mass, metabolism, and hormones will affect the dose of
opioids you need to get the desired effect and how much you can tolerate.    
Naloxone (Narcan®) is a medicine that reverses overdose from opioids
including heroin, prescription pain pills, and fentanyl. If you think it is possible
someone has overdosed, give naloxone. Giving naloxone to someone who has
not overdosed on opioids will not hurt them; it just won't work.
OPIOIDS
OPIOID OVERDOSE + PREGNANCY
SOAP
If you use opioids, get naloxone.
Get naloxone (Narcan®) training:
If you love someone who uses opioids
get naloxone. 







Place the person in the recovery position on their
left side to improve the blood flow to the placenta.
 
Stay with the person or find someone who can.
 
Although there is no research on overdose reversal in pregnant people,
there are things you can do to protect the pregnant person and their fetus
during a suspected overdose:
 
Many states have Good Samaritan Laws which may protect you from
being arrested when calling for help.  Look into the policies in your state.   
 
911
New York State's 911 Good Samaritan Law Protects YOU.
Because overdose reversal with naloxone can cause immediate
withdrawal, it is possible that both overdose and overdose reversal
could cause stress to your pregnancy and increase your risk of
complications.
 However, the risks posed by oxygen deprivation or even death from






in a pregnant person
exactly the same as for
anyone else.
OPIOIDS
OPIOID OVERDOSE + PREGNANCY (CONTINUED) 
Call 
 
Tell the dispatcher that you are with a pregnant person
who is not breathing and you need paramedics.
911.
You do not need to tell them that this may be a drug poisoning






Tell the dispatcher that you
are with a pregnant person
who is not breathing and
you need paramedics.
 
If you think they have injured their







Many states have Good
Samaritan Laws which may
protect you from being
arrested when calling for
help.
Respond to overdose in a pregnant person 
exactly the same as for anyone else.
Place the person in the
recovery position on
their left side to
improve blood flow to
the placenta.
 
When overdoses happen, giving naloxone (Narcan®) saves lives 
- including the lives of pregnant people and their babies




The risks of stimulant use during
pregnancy are not entirely clear,
however many of the reported risks
during the so-called “crack baby
epidemic” of the 1980s and 1990s
were incorrect. These accounts were
used to punish Black parents and
families and resulted in the forced
separation of many families. 
The risks of using stimulants during
pregnancy are now better
understood. 
Overdosing or overamping on
amphetamines can stress the
pregnant person’s body; it is rare
but still possible to overdose and
die from methamphetamine or
cocaine use as these can stress
the heart and circulatory system
(often these substances are used
along with many other substances,











(Adderall® and Dexedrine®). 
Caffeine, cocaine, amphetamines,
and methampethamines are




Stimulants can be linked to preterm
premature rupture of membranes
(PPROM). PPROM occurs when the sac
that contains the amniotic fluid breaks
before 37 weeks of pregnancy.                   
There is no evidence of stimulant
withdrawal in infants with prenatal
exposure. 
Long-term outcomes are similar to
other children in the same peer
group.  One study that followed meth
exposure during pregnancy and
outcomes in children 7.5 years later
found there may be an increased risk of
the child having behavior issues,
however poverty and negative childhood




Stimulants may cause decreased
blood flow to the placenta. They can
also increase blood pressure which
increases the risk of preeclampsia, 
a dangerous condition in pregnancy
which can cause seizures, heart
attack, stroke and pulmonary edema
(fluid in the lungs). 
There is currently no direct link
between stimulant use and placental
insufficiency (lack of a good supply of
nutrients and oxygen delivered to
fetus through the placenta). 
Stimulants have not been linked to
birth defects or placenta previa (when
the placenta grows over the opening
to the birth canal).  
Stimulants may cause decreased
birthweight, but the evidence is not
clear, because other factors such as
cigarette smoking and poor diet can
also cause low birth weights. 
25, 50-56
24, 25, 50-53, 55-57
.




Placental abruption (the separation of
the placenta from the uterine wall)
has not been linked to caffeine or
methamphetamine, but there is
evidence linking it to cocaine.
However this evidence is of very poor
quality and does not adequately
control for confounding factors.  Even
with this link, the chance of this
happening is low.   31, 61-63, 65, 88
It is recommended to discard milk for 24 hours after cocaine use, and 48 hours
after methamphetamine use. During this time, continue to pump and dump so
that your supply does not decrease.
Both cocaine and methamphetamine are excreted in the human milk and
there have been reports of severe infant effects from cocaine overdose, and one
death after methamphetamine exposure via human milk.    
In some states, new parents have been convicted of child endangerment or even
manslaughter if the infant death was related to breast/chestfeeding and
methamphetamine consumption.  
1 to 2 cups of regular coffee (8 oz)
5 cans of soda (12 oz)
2 cans of energy drink (250 mL)
Stimulant use can decrease the amount of milk you produce,







STIMULANTS + LACTATION 
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67- 69
Up to 200 mg of caffeine per day is considered safe: 69, 70










Currently, there are no FDA-approved medications for the treatment of
stimulant use disorder. 
However there are some "off-label" uses of medications that may be helpful.
The off-label use of medications is common and is the norm for
medication taken during pregnancy and lactation because few drugs
are tested on pregnant and lactating people. Off-label prescribing is
when a physician gives you a drug that the U.S. Food and Drug
Administration (FDA) has approved to treat a condition different than your
condition or approved for your condition when someone is not pregnant or
lactating.
Topiramate (Topamax®), modafinil (Provigil®), ondansetron (Zofran®), and
prescription stimulants - amphetamine (Adderall® and Dexedrine®),
dextroamphetamine and dexedrine (Dexedrine®, Spansule®, ProCentra®,
and Zenzedi®), atomoxetine (Strattera®), methylphenidate (Ritalin® and
Concerta®) - have been studied in non-pregnant people and have been
helpful in some cases but not all.                            
Some people find that group or individual therapy 
is helpful - especially when done with those who
understand substance use and substance use disorders.




What treatment options are available for
stimulant use disorder during pregnancy?
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but these can sometimes be stigmatizing or shaming to
pregnant people.
UptoDate: Contingency management for substance
use disorders
Contingency management (the use of variable
rewards for having negative urine toxicology) has
been shown as useful in the treatment of people
with stimulant use and other substance disorders.   
or 
72
Tobacco is a leafy plant that contains
large amounts of nicotine, a chemical
that affects the brain. 
Most of the health problems
associated with tobacco products are
thought to be the result of smoking,
and not related to the nicotine. 
That’s why smokeless nicotine
delivery systems like gum, patches,
and e-cigarettes are considered to be
less harmful.
E-cigarettes (vapes) have only been
around for a few years, so there is not
robust information about their health
effects, but the information that exists
suggests that they are less harmful for











This is a list of tobacco and nicotine









Unregulated vape products, like those
containing vitamin E oil, have been
associated with serious respiratory
illness called e-cigarette and vaping
associated lung injury.
Some vape cartridges have very
highly concentrated nicotine. Some
have less - or none.
What you vape matters. 
www.harmreduct ion.orgwww.per inatalharmreduct ion.org
73-75
TOBACCO + NICOTINE
Most of the research regarding tobacco, nicotine and
pregnancy is conducted with pregnant people who
smoke cigarettes. 
Smoking cigarettes has been linked to early birth,
smaller birth weight, placenta problems, birth
defects, breathing problems through childhood, and
even Sudden Unexpected Infant Death
Syndrome/Sudden Infant Death Syndrome
(SUID/SIDS) or unexpected death under one year of
age.
People who are able to reduce their smoking or quit
during pregnancy decreased the risk of SUID by 12
to 21 percent, so it is recommended to smoke as few
cigarettes as possible.  
Nicotine has been shown to affect the
development of the baby’s brain and may increase
the risk of attention deficit disorders.      
Babies might experience nicotine withdrawal which
makes them irritable and hard to console. 
In addition, nicotine withdrawal has been shown to
worsen neonatal withdrawal from opioids.  









Children that are exposed to second-hand or third-hand smoke (residue left on clothes
or surfaces in the home) can have increased risk of ear infections, coughs, colds,
breathing problems (asthma, bronchitis and pneumonia), tooth decay and ongoing
exposure to cancer-forming chemicals formed by cigarette smoke or vapes.    
Children with this exposure could grow up to have increased risk of cataracts, heart and
lung disease and asthma. 
TOBACCO + NICOTINE
TOBACCO + NICOTINE + LACTATION 
Smoking may decrease milk production and/or
cause the milk to dry up earlier. 
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Nicotine and other harmful substances in cigarettes
can pass to the baby from human milk. 
It’s important to remember that even though there
are risks from smoking and breast/chestfeeding,
it is still considered better to breast/chestfeed
and smoke than to formula feed and smoke.   18, 85, 86
CHILDREN + SMOKE EXPOSURE 
87
18, 84
What treatment options are available for
people who are pregnant?
There are many different options to help people reduce or quit smoking.
You can get patches, gum, lozenges, or e-cigarettes without a prescription.
Insurance may cover gum, patches, or lozenges with a prescription from a
healthcare provider. 
Healthcare providers can also prescribe nicotine nasal sprays, inhalers, or
medications like bupropion (Wellbutrin®) or varenicline (Chantix®) to help
their patients reduce or quit smoking. As with many other medications, these
medications have not been studied in pregnant people.  
87
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Substance use during pregnancy is a
complicated medical and legal
situation to navigate. 
You might be anxious about what
may happen if you are open about
your substance use. 
In this section, we present you with
the federal laws around this issue (as
well as New York State specific laws
and policies) and some information
about what might happen if you do













Please note that laws will vary
widely by state and some providers
and agencies might interpret the
law differently than it is written.
So please consult with local
agencies that have expertise.
SECTION 3









Birth Rights Bar Association
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Ideally, healthcare decisions are
made collaboratively between a
patient and a medical provider/team. 
A provider that is informed about all
aspects of your health is better able
to provide the care that is most
appropriate and refer you to needed
services. In some states, substance
use during pregnancy is so
criminalized that some experts
recommend consulting with a
lawyer before disclosing use to a
doctor. 
Having a provider you can trust is
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In New York State, if you are pregnant and want to get on
buprenorphine or methadone you can skip the waitlists. 
For more about pregnancy and substance use treatment in New York
State, visit the Office of Addiction Services and Supports website
or call (518) 473-3460.
      oasas.ny.gov/treatment/pregnant-and-parenting
24/7 HOPEline: Call 1-877-8-HOPENY  or text 467369
You might need to meet with a couple
of different providers before you find
one that is right for you.
Getting prenatal care can improve
birth outcomes l ike making sure the
baby is full-term and a healthy size. 
Substance use can cause health
problems that may or may not be
obvious. For pregnant people, there
are some potential risks that a
provider can help with if they are
informed of the whole picture. 
Starting methadone or
buprenorphine can help reduce
many of the risks of il l icit opioid use
while improving both parental and
infant outcomes. 
Learn About Your Treatment Opt ions
BUILDING A RELATIONSHIP
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If you have used substances during
your pregnancy, it is beneficial to
build a supportive network to help
navigate these systems. This can
mean friends and family, social
service providers who work with
people who use drugs, as well as
doulas.  
Deciding to disclose your
substance use to your provider is
a personal decision.  
Your healthcare provider may
become aware of your substance use
even if you don’t share this
information with them, so it can be
helpful to prepare a plan ahead of
time.  Preparing this plan can help to
show your providers what a great
parent you will be.  
This "Plan of Safe Care" template
(sample version from New York State
is attached, see Appendix B for
printable version) could help you
think through a plan. 
If you believe that a case will be
opened, reach out to a legal group
in your area as soon as possible.     
www.harmreduct ion.org
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ADVOCACY
Plan of Safe Care
Template from New York
State, see Appendix B
for printable version
www.per inatalharmreduct ion.org
It is not mandatory for New York
State healthcare providers to test
pregnant people for drugs or to
report pregnant or parenting
clients with substance use to
child welfare or law enforcement
agencies (see Appendix A). 
However, many healthcare
providers are poorly informed
about the laws around mandatory
reporting or are following guidelines
developed by their hospital (which
are not based on the law). 
This means that if a pregnant
person tells their provider they’re
using drugs, it is likely this
information will be shared with
Child Protective Services. 
A report can be made by anyone in
your life, such as a nurse, doctor,
lactation consultant, friend or family
member or a neighbor.  
In an ideal scenario, this would
mean that parents are provided with
resources and support for parenting
and healthcare. 
People often choose not to
disclose to their provider for these
and other reasons.  There is often
fear (from personal experiences and
those of friends and family) and lack
of information about what will happen
to you if you access prenatal care
while pregnant and using drugs. 
It can be difficult to decide whether
or when to tell a healthcare
provider about your substance use. 
If they don’t know this is an issue,
they cannot connect you with
resources that may be helpful, and
they may find out later anyway.
Because of this, it might make sense
to tell them about substance use
early in the relationship.
Providers are more likely to be
understanding if they feel they
know everything going on with you
from the beginning. 
  
NAVIGATING THE HEALTH CARE + LEGAL SYSTEMS
DISCLOSURE 
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In many cases however, the main
result is agency surveillance (ex:
unannounced home visits, speaking
with friends and family) and
removal of the baby and any
other children.
www.harmreduct ion.org
TALKING TO YOUR HEALTHCARE PROVIDERS ABOUT SUBSTANCE USE
S A F E T Y
T R U S T
www.per inatalharmreduct ion.org
There are many ways that a provider might become aware of your
substance use, including talking to you or performing tests on your hair,
blood, or urine. 
The most common is a urine drug screen. Most drug screens work by
checking for the byproducts of drug metabolism. These tests can
sometimes be inaccurate (false positives or false negatives, meaning the
test might show a substance when none was actually taken or might not
show a substance even if one was present).
Substance Abuse and Mental Health Services Administration (SAMHSA),
American College of Obstetricians and Gynecologists (ACOG), and other
expert medical associations agree that any positive screening result
should be confirmed with a second, more accurate test (for example, a
urine test might require additional confirmatory urine and/or blood tests).
NAVIGATING THE HEALTH CARE + LEGAL SYSTEMS
TYPES OF DRUG TESTING (TOXICOLOGY)
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Drug screens are not good evidence and should not be used as such in
legal matters.    Despite this, they are often held against people – whether
or not confirmatory results have been completed. A confirmatory test takes




ACOG Committee Opinion: Substance Abuse Reporting and Pregnancy:
The Role of the Obstetrician-Gynecologist
SAMHSA: Clinical Guidance for Treating Pregnant and Parenting Women 
With Opioid Use Disorder and Their Infants 
4, 8
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You can make a plan with your
support system before engaging in
care and decide the pros and cons
of sharing information about your
substance use with your provider. 
 This is a case-by-case decision that
you can make based on how you
think your provider will respond.  
In situations like this, it is especially
helpful to have a friend, family
member, or doula with you to weigh
these decisions. Having others join
you at your appointments and labor
can also help to demonstrate that
you have a strong support system.  
It is important to note though, that
your prenatal provider may not be
the provider that is present during
your labor. Any member of the team
could file a report, even if other
providers on your team do not want a
report filed. 
If a report was made and it becomes
an investigation, your prenatal
provider could be required to
speak about your discussions.    
MAKING A PLAN
www.harmreduct ion.org




Many providers test urine or other
body fluids without asking or even
informing clients. This is bad practice
and is not legal. 
You have a right to know what tests
are being performed on you, why, and
how the results will be used. 
Ideally, they will give you a written
document to sign before performing
any tests (alternatively they ask you for
permission during a conversation,
which is verbal consent).  
You have the right to decline any test
or procedure. But if you decline a drug
screen (test), some providers will
assume it would be positive. This can
lead to biased treatment. 
 
Check out Birth Rights       a
resource from NAPW and the Birth
Bar Association to help you




This is when court proceedings begin.
You will need a lawyer. The court will
appoint you one but they may not be
an expert in this kind of advocacy.
There may be an organization in your
area who can provide you with free
legal counsel.
FINDING     SUSPICION
With or without your
permission, CPS will talk with
family, friends, and providers
about you and your parenting
ability. There will be home
visits.  Now is the time for your
support system to advocate for
you. Things may be presented
as voluntary even though you
feel like you have no choice. 
 You may want to seek legal
counsel at this stage to help
you navigate this. 
REPORT







PATHWAYS      CHILD PROTECTIVE SERVICES INVOLVEMENTFOR
A COURT CASE IS OPENED
Hospital staff may inform you










states to make sure
infants identified as being
affected by substance use
have a Plan of Safe Care
(PSC).  You are entitled to
help create the plan and
to see it. 
www.harmreduction.org
This is the hospital's internal process for documentation. This
is among providers at the hospital. It is based on the initial




Many of the decisions made by people
involved in these systems, such as a
decision by a doctor to test someone for
drugs, a nurse to call in a CPS report, a
case worker to deem a situation unsafe,
are up to that individual.  
This means that this system, like all
others, favors those with the most
privilege in our society.  Those who are
Black and Latinx, poor, un-housed, and
have familial structures deemed
"untraditional" are under the most scrutiny
and are most likely to be tested for
substance use, have reports filed, and
lose custody of their children.  
CASE WORKER ASSIGNED
If you have previously
had your parental rights
terminated, CPS may




This may be based on: 
Diagnosis of a substance use disorder 
Positive urine or blood toxicology
Due to the Adoption
and Safe Families Act
(ASFA), if your child is
out of your custody for
15 out of 22 months,
you parental rights may
be terminated. 
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attending a treatment program
going to parent-infant classes
getting medical care
consenting to unannounced
"check-ins" and home visits
Taking opioid agonist treatment (methadone and buprenorphine)
A record of taking controlled substances (prescribed or unprescribed)
www.perinatalharmreduction.org
It can be helpful to have another person
with you throughout this process to help
advocate.
Having a record of what happened will
help you advocate for yourself if your
rights have been violated.
Contact the patient advocate
associated with the facility, which is a
person whose job is to assist the facility
and any patients who have experienced
poor care or have a complaint. 
If your concern is not resolved, you can
file a grievance with the government or
the facility. Many people find the patient
advocates and the grievance process to
be discouraging.
To file a grievance if you have
Medicaid insurance, go to the website
for the Center for Medicare and
Medicaid Services.
If you get a result on a drug screen or
any test generally that you disagree
with, you have the right to ask for a
second confirmatory test. 
If the results of the test are to be used
in legal matters, such as criminal
prosecution or child custody, the test
should be a forensic test. A forensic
test is more accurate and every step
of the process is documented. This is
the only kind of test which technically
can be used as evidence, but
unfortunately this is often
disregarded.   
If you are concerned that you are
being mistreated, it is important to
keep records of your appointment
dates, the names of your providers,
and what happened at each
appointment. 
www.harmreduct ion.org
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IF THERE ARE PROBLEMS
4
See Section 4:





The Child Abuse Prevention and
Treatment Act (CAPTA) is a federal
law directed only to states, not to
hospitals or individual healthcare
providers. 
CAPTA requires that if states want
to have the benefit of certain
federal funds, they must provide an
assurance that their state has a
system for notifying the child
protective services system of the
occurrence of certain conditions in
infants.  
These conditions are: 
CHILD ABUSE PREVENTION
AND TREATMENT ACT 
FEDERAL LEGISLATION THAT MAY AFFECT YOU: 
when infants are born “affected
by substance abuse” (a term
not defined in the statute). 
when infants have “withdrawal
symptoms resulting from
prenatal drug exposure.”
when infants are diagnosed with
“a Fetal Alcohol Spectrum
Disorder.”
There is no federal law that
requires all pregnant people be
tested for drugs.
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A 2016 federal amendment passed
by Congress requires that a "Plan
of Safe Care" (See Appendix B)
must be developed for all infants
with these conditions. These
plans must include the needs of
the affected family and/or
caregiver.
States can decide where reports
are directed, as well as who is
responsible for developing and
monitoring the Plan of Safe Care
and may establish a reporting
system that does not make
families vulnerable to allegations
of or investigations for child
abuse or neglect.  
For more information about how
CAPTA relates to you, please see
the fact sheet from National
Advocates for Pregnant Women:
Understanding CAPTA and State
Obligations.
www.harmreduct ion.orgwww.per inatalharmreduct ion.org
www.harmreduct ion.org
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New York State law does not require drug testing of
pregnant/postpartum people or newborns and does not mandate reporting
of positive drug tests or evidence of prenatal exposure to criminalized
substances, alcohol, or tobacco. 
New York State does not define substance use alone as civil child
abuse or neglect. But many child welfare workers may open a case based
on use of criminalized substances.
If you have already had children in the system, or if you were involved in
the system as a child, it may be more likely that a case will be opened
based on your substance use.
It is a very personal decision whether you choose to share with your provider
regarding your substance use.  There are some drawbacks to sharing this
information (your provider may make a report to their hospital or child
protective services) and there may be benefits to sharing this information
(your provider may connect you with important resources, appreciate your
honesty and advocate for you if a report is made).  The laws and protocols
will differ based on where you live, so try to get in touch with local resources
to get information about what you can expect about drug testing or Child
Protective Services involvement.  Don’t forget that you do not need to make
these decisions alone. Friends, family and doulas can help you make a plan
for your birth, and advocate for you in the event that a report is made.  
For more information on New York State protocols, see Plans of Safe Care
for Infants and their Caregivers       from the New York State Office of





New York State Office of Children and Family Services
Child Protective Services Policies 
Excerpt from the Office of Children and Family Services 
Child Protective Services Manual 2019  E7-8, pg. 355-356. 
Parent's Drug / Alcohol Misuse
The misuse of legal or illegal drugs or alcohol by a parent or other person
legally responsible for the care of a child can result in harm or imminent
danger of harm to a child's physical, mental or emotional condition. The key
issue to determine is whether the parent has misused a drug or drugs or
alcoholic beverage to the extent that he/she loses self-control of his/her
actions and is unable to care for the child, has harmed the child, or is
substantially likely to harm the child. The fact that the parent or person
legally responsible is voluntarily and regularly participating in a rehabilitative
program is irrelevant in assessment of whether child abuse or maltreatment
has occurred if the child's physical, mental or emotional condition has been
impaired or is in imminent danger of impairment due to the parent's acts or
omissions. 
Evidence that a newborn infant tests positive for a drug or alcohol in its
bloodstream or urine; is born dependent on drugs or with drug withdrawal
symptoms; demonstrates fetal alcohol effect or fetal alcohol syndrome; or
has been diagnosed as having a condition which may be attributable to in
utero exposure to drugs or alcohol is not sufficient, in and of itself, to
support a determination that the child is abused or maltreated. In addition,
such evidence alone is not sufficient for a social services district to take
protective custody of such a child. However, such evidence alone is
sufficient to constitute reasonable cause to suspect that the child is at risk of
being abused or maltreated in the future, thereby warranting a report to the
Statewide Central Register of Child Abuse and Maltreatment (SCR) and the
commencement of a child protective investigation.
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APPENDIX A:
What is the child's physical, mental, or emotional condition? Has the child
been harmed or in imminent danger of harm?
What is the parent's/other person legally responsible’s explanation for
these conditions? Good note taking is essential. Use direct quotes.
What are the results of medical examination concerning the parent's drug
or alcohol use?
What is the parent's/other person legally responsible’s capacity to
exercise a minimum degree of care to meet the child's physical, mental
and emotional needs?
Upon the receipt of a report where parental drug or alcohol misuse is
alleged, the social services district must conduct a thorough investigation to
determine whether such misuse creates a risk to the child. The district must
assess the ability of the parent to care for the child. The district must
examine, in particular, the parent's plans for the care of the child and his/her
ability to carry out those plans to determine whether the parent's drug or
alcohol use creates a condition which places the child's physical, mental or
emotional condition in imminent danger of becoming impaired. In the case of
a newborn infant born to a drug or alcohol abusing parent, any special needs
of such infant should be considered in the district's assessment of parental
capability.
Immediate considerations:
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APPENDIX A continued
Plan of Safe Care 
Excerpt from the Office of Children and Family Services
Child Protective Services Manual 2019 J4-5, pg. 168-169. 
Creating a Plan of Safe Care
The federal Comprehensive Addiction and Recovery Act of 2016 (CARA),
which amended the Child Abuse Prevention and Treatment Act (CAPTA),
tackles some of the complex issues surrounding the nation’s prescription
drug and opioid epidemic. 
CARA places a strong emphasis on a multi-agency approach to the problem
of substance abuse. CARA changed some of the requirements for developing
a plan of safe care for infants exposed to substances. These changes reflect
a growing body of evidence that supports a collaborative approach between
various agencies and providers when responding to the challenges and
complexities of dealing with substance use disorders.
The OCFS policy, 17-OCFS-LCM-03, Amendments to the Federal Child
Abuse Prevention and Treatment Act by the Federal Comprehensive
Addiction and Recovery Act of 2016 and Corresponding State Requirements,
provides guidance to CPS on complying with the new requirements set forth
in CARA for handling cases in which an infant has a positive toxicology or
shows signs of withdrawal symptoms, or Fetal Alcohol Spectrum Disorder
(FASD).
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APPENDIX B:
Requirement to Create a Plan of Safe Care
Under CARA, whenever an infant is identified as being exposed to
substances, the state must provide for the development of a plan of safe
care that addresses the health and substance use disorder treatment needs
of both the infant and the affected family or caregiver. The plan of safe care
must address not only the immediate safety needs of the affected infant, but
also the health and substance use disorder needs of the affected family or
caregiver. A plan of safe care should include referrals to appropriate
services that support the affected infant and family or caregivers.
The plan of safe care should be developed with input from parents and
caregivers, as well as from professionals and agencies involved in serving
the affected infant and family. It may be written by a physician, other
medical provider, CPS, social worker, or another entity. 
CPS Documentation Requirements for the Plan of Safe Care
Whenever a report of suspected abuse or maltreatment involves an infant
exposed to substances, CPS must document the plan of safe care in its case
records. In some instances, a plan of safe care may have been developed
by medical professionals and/or substance abuse treatment providers prior
to the involvement of CPS. The case file should clearly document the plan of
safe care, whether developed by CPS or other professionals involved.
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APPENDIX B continued
A Plan of Safe Care is Not the Same Thing as a Safety Plan
A plan of safe care, as described above, is a document and plan that
specifically addresses children affected by substance use and the
parent/caregiver. A Safety Plan is a plan developed by an LDSS in
partnership with the parent/caregiver that includes controlling interventions
to address safety factors that would place a child in imminent danger of
serious harm. A plan of safe care might be included as part of a Safety
Plan, but is never a substitute for one.(See Chapter 6, D.2, The safety
assessment process).  
In 2018, OCFS issued OCFS-2196: Plan of Safe Care (see Chapter 14,
Appendix), which is the required form to be used when developing a plan of
safe care with a family. Completion of the OCFS-2196 should be
documented in Progress Notes, including a description of how the family
was involved in the creation of the plan and how the plan will be monitored
and adjusted as necessary.  A paper copy of the plan must be maintained in
the case file. 




Medicaid in New York State
Accessing prenatal care is the
single most important thing you can
do -- not only for parental, fetal, and
infant health, but also to prepare for
any legal challenges that may occur. 
If you are labeled by healthcare
providers as "late to care" (seeking
care after 20 weeks of pregnancy)
you can face additional barriers when
seeking quality healthcare and are
more likely to be referred to child
welfare.
www.harmreduct ion.org
Be prepared to advocate for yourself
and your family. Keep records of
phone calls, appointments, and any
other information relating to your
prenatal care.
The next page has a template you can
print out to keep track of this
information.  
Be sure to start taking prenatal
vitamins as directed by your medical
provider and get enrolled for prenatal
care with your health insurance
provider as soon as possible.
New York State Medicaid can help you get the care you need for you and your
baby. 
Pregnancy care and other healthcare services are available for people who live
in New York State and are eligible for Medicaid.
To see if you can access Medicaid programs for pregnant people, call the













MY EXPECTED DUE DATE:
pregnancy test
MY FIRST APPOINTMENT WAS
I WANT TO GIVE BIRTH AT:
MY SUPPORT NETWORK :





printable - My Pregnancy
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MY PRENATAL CARE
PROVIDER:                           DATE:
APPOINTMENTS
cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t









I f  I  have quest ions I  can
My choice for bir th control  is:
My goal  for  another pregnancy is:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
PROVIDER:                           DATE: cal lof f ice v is i t
NOTES:                                 FOLLOW-UP:
NOTES:REFERRALS:
I  should make an appointment wi th. . .
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Healthcare providers in the field of
obstetrics and gynecology (OB/GYN)
may have not received much
training about substance use and
other mental health issues. 
In addition, providers in the fields of
substance use and mental health do
not receive much training about
pregnancy. 
This lack of knowledge and
experience can cause them to feel
uncomfortable addressing or even
acknowledging the impacts of health
concerns outside of their area of
expertise. For you, this can result
in mixed messages or lack of
accurate information.
It can be frustrating to work with
providers who are uninformed or
who might seem uninterested.
If it seems that services provided
to your family overlap with or
contradict another part of your
treatment plan, ask for a care
conference or for someone to be
designated as your care
coordinator.
Anyone you feel comfortable with
knowing your healthcare
information can step into the role
of care coordinator.
Keep in mind that effective
communication between
providers can ease the workload
on everyone and avoid duplicate






WIC (Women, Infants, & Children) program provides nutritious food,
education, referrals, and breastfeeding support for pregnant people and
parents of young children. Visit www.wicstrong.com/about/eligibility 
Use the pre-screening tool at wic.fns.usda.gov/wps/pages/preScreenTool.xhtml
During pregnancy, good nutrition supports the healthy development of the
fetus and increases the chances of delivering on time, without
complications. Good nutrition also protects your health during pregnancy and
delivery, reducing the risk of nutritional deficits.
Eating a lot of fruits, vegetables, whole grains, and lean protein is the
foundation of good nutrition for anyone, but especially when you are pregnant.
We recognize that due to food deserts and prohibitive costs, not all of these
options are available to everyone.  As possible, eat lots of foods that are high in
nutrients needed in pregnancy like:












mango, papaya, passion fruit
apricots, plums, peaches
oranges, lemons, limes, grapefruit
nuts, seeds, rice
peas, beans, lentils, chickpeas
soy, edamame, tofu
eggs, chicken, turkey, duck
beef, pork, goat, lamb
fish, shellfish, shrimp (in moderation)
NUTRITION
WIC
FOOD and NUTRTION PROGRAMS 
for PREGNANCY and BEYOND
You can also apply for Supplemental Nutrition and Assistance Program (SNAP).





Raw sprouts (like alfalfa, clover,
radish, and mung bean sprouts)
Certain seafood that is high in
mercury (like shark, swordfish,
king mackerel, tilefish, bigeye
tuna, marlin, and orange roughy)
There are some foods you should
avoid, due to the risk of infections
or contamination. These foods
include:
Although fish is very healthy, it’s
important to be careful about how
much and which kinds of fish you
eat during pregnancy because of
the risk for mercury contamination.




Even with a healthy, balanced diet, most pregnant
people still need prenatal vitamins to get enough of
the most important nutrients. 
For example, folic acid is needed to help the fetus's
brain develop. It is important that you have enough
calcium during your pregnancy to make sure your










Store and prepare fruits +
vegetables, meat, and
eggs separately.
Keep most foods chilled
and refrigerated.







People may have some nausea and even vomiting during pregnancy.
For most people, it is in the morning, but it can happen at any time. If you
experience “morning sickness,” drink fluids and eat bland foods, including
whatever sounds good and stays down. 
Other strategies to minimize nausea are eating many small meals
throughout the day and taking vitamin B6 supplements. There are also anti-
nausea medications that are considered safe in pregnancy that can be
prescribed by your doctor. 
PRENATAL CARE
Some people find that cannabis helps them with nausea during
pregnancy but other people have experienced increased nausea with
cannabis use in pregnancy.
The safety of cannabis use during pregnancy is not agreed upon,
though studies are currently being done in states where cannabis is
legalized.  It is safest not to use if there is an alternative. 
Talk to your provider about the safety of other nausea medications. 
See Section 2: Harm Reduction for more information
For most people, morning sickness is an unpleasant, but not
dangerous experience, but for some it can become severe and even
life threatening. 
Hyperemesis gravidarum is nausea and vomiting so severe that you are
unable to eat or drink anything, even water. It is very dangerous because
it can cause severe dehydration and loss of nutrients and electrolytes. If






Routine prenatal care is the healthcare that every pregnant person should
get during the normal course of their pregnancy. In other words, it is the
standard for clients with no complications or known risk factors.
Prenatal care increases the chance of having a healthy pregnancy,
delivery, and baby. In fact, accessing prenatal care is the single most
important thing you can do to have a healthy pregnancy. Going to more
prenatal visits as early as possible has been found to decrease the risk of
premature birth, low birth weight and being small for gestational age
among babies born to people who use drugs. 
If there are complications or your pregnancy is considered high-risk,
routine prenatal care plus additional interventions are recommended. This
usually involves more frequent visits, and tests that are specific to your
unique medical needs.  You might be referred to a specialist in Maternal-
Fetal Medicine. 
Multiple gestation (twins and multiples) 
Teenage or over 35
A history of pregnancy complications
ROUTINE PRENATAL CARE
Condit ions that Make 
a Pregnancy High-Risk
Chronic health conditions (e.g. hypertension, seizure
disorders, diabetes, cerebral palsy, asthma, HIV)
Using some medications (e.g. lithium, chemotherapy agents, etc.)
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Ideally, everyone would see a provider for pre-pregnancy planning, but most
people schedule a visit for the first time when they first suspect they’re
pregnant.
For most people, this is around 8 weeks, but if menstruation is not regular
(as is common for people who use drugs) it may be later. 
 
For first-time, low-risk pregnancies the usual prenatal care schedule is:      
PRENATAL CARE
The ear l ier  prenatal  care is in i t iated, the better.
Those who are high-risk should be seen more often.
 
Following this schedule, a person with a low-risk pregnancy who
sees a provider for the first visit at 6 weeks and the last visit at 40 weeks
will have 15 prenatal care visits.      
every 4 weeks until 28 weeks of pregnancy
every 2 weeks from 28-36 weeks

































Prenatal care is considered to be late if started after 20 weeks of pregnancy.
It is considered inadequate if clients miss over 20% of appointments. 
If possible, go early in pregnancy and go often. This shows your providers
that you care about the health of your pregnancy. 
One of the risks pregnant people face is being
labeled as “late to care” or having received
“inadequate care.” These patients are more












leaking amniotic fluid 
preterm labor contractions
severe, persistent headache
the baby moves a lot less
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vaginal bleeding
leaking of amniotic fluid (some people think they are wetting their pants)
lower backache
feeling of pelvic pressure
contractions (may feel like menstrual cramps or the urge to have a
bowel movement)
This can occur anytime during pregnancy and is
dangerous if it happens before 37 weeks. 
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Uterine rupture is when the uterus tears. This can cause fluid to leak into the
abdomen, endangering the pregnant person and the baby. The signs of
uterine rupture may include chest or belly pain, bleeding, dizziness, difficulty
breathing, or fainting.
Preterm labor can happen any time between 20 and 37
weeks of pregnancy. Preterm labor can be dangerous for
you or the baby. Signs of preterm labor are leaking of fluid
from your uterus through your vagina, or contractions. It can
be difficult to tell if preterm labor is really happening, so see
a healthcare provider right away if you are not sure.
PLACENTA PREVIA
Placenta previa is when the placenta grows over the opening of the uterus.
Usually if this happens, it moves out of the way as the pregnancy progresses
and the uterus stretches. Your healthcare provider can see on the ultrasound
if this is happening. If the placenta remains over the opening, it can cause
bleeding when labor starts and prevent the baby from coming out through
the vagina. Bleeding without pain is the most common sign of placenta
previa.
Placental abruption is when the placenta starts to detach from the uterus
before the baby is born. This causes the blood vessels between the placenta














You have the r ight to decl ine any test  for  yoursel f  but,  in
most states,  once the baby is born, providers do not need
your consent to test  the baby and they don’ t  have to inform
you of any infant test ing. I t  is  best pract ice for providers to
work col laborat ively wi th parents regarding any tests or
intervent ions the infant receives.
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PARENT-TO-CHILD DISEASE TRANSMISSION
Testing for HIV, Hepatitis B, and TORCH infections (Toxoplasmosis, Other
[syphilis, varicella, parovirus, etc], Rubella, Cytomegalovirus, and Herpes)
These infections pose serious risks to the fetus/newborn, so testing for them
is important. These tests will be conducted at your first prenatal visit, and if
any of them are positive, treatment or other steps can be taken to decrease
or eliminate risks.  There is a lot of information on these conditions
accessible online from experts in these fields.
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Hepatitis B and Pregnancy
Hepatitis B and C and Pregnancy
HIV and Pregnancy 1
HIV and Pregnancy 2






and require higher doses of pain
medication to feel pain relief.
In addition, many people who use
substances have had negative
experiences with healthcare and
may have been labeled as “drug-
seeking” and denied pain relief
based solely on their status as a
person who uses substances. 
These past traumas can lead to fear
and anxiety as the due date
approaches.  This is normal.  Speak
with someone in your support
network about ways they can help
you.  
Many people are concerned about
the pain related to labor and
birth. 
There are many options you can
discuss with your provider.  If you
know more about your options,
you can make decisions that
make you feel more confident and
safe as labor approaches. 
You may also share this information
with your provider who may not be
familiar with the specific issues
faced by people who use drugs
when choosing a pain control plan.
For people with a history of
substance use, pain control can be
complicated.
We know that people who use
opioids might have higher tolerance 
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SECTION 5
See Section 1: Quality Healthcare
Is Your Right, for more information
on trauma-informed care and
Section 4: Prenatal Care for
information on care coordination.
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The epidural is the most well-known form of labor pain control. 
It is considered regional anesthesia because it makes a large portion of the
body numb. Usually it is an anesthetic combined with an opioid administered
through a soft flexible tube inserted between the layers of the spinal cord
sheath in the lower back. 
An epidural works by almost completely blocking nerve function below the level
of the injection. You will still feel pressure and stretching, but not pain. It is
effective within 10-25 minutes, and starts to wear off mostly in a few hours, but
can take up to 24 hours after the tube is removed to completely wear off. 
This section provides a brief
overview of some common pain
control methods used for labor. 
Use this information to start a





PROS  CONS  
effective pain control
long lasting
pregnant person stays alert
does not pass to baby
cannot walk
will likely require a catheter
potential for complications such
as infection or nerve damage
can slow labor and increase risk
of cesarean section
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Spinal anesthesia is usually used for cesarean section, unless an
epidural is already in place. It is similar to an epidural, except that the
medications are injected inside the spinal cord sheath, rather than between
its layers. This results in faster pain control, within a few minutes. 
The other difference is that the tube is not left in place, and the pain relief
wears off in a few hours, depending on which medication was used. Spinal
anesthesia can take up to 24 hours to wear off completely.
LABOR + CHILDBIRTH
SPINAL  
PROS  CONS  
effective, fast pain control
long lasting
pregnant person stays alert
does not pass to baby
cannot walk
will likely require a catheter
potential for complications such
as infection or nerve damage
COMBINED EPIDURAL OR "WALKING EPIDURAL"  
A combined spinal epidural (aka “walking epidural”) can be used to
decrease pain without interfering as much with movement. Despite the
name, most people will not be able to walk safely without assistance, but
they will be able to move more than if they received a standard epidural.
Most patients report that pain is not eliminated but is decreased to a
tolerable level. An epidural catheter is placed and much lower dose of
medication than traditional epidural is injected. Pain control is achieved
within a few minutes.
PROS  CONS  
effective, fast pain control
long lasting
pregnant person stays alert
does not pass to baby
allows more movement
cannot walk without assistance
will likely require a catheter
potential for complications such as
infection or nerve damage
less complete pain control than
traditional epidural
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This is not typically used unless there is an emergency, because there are
increased risks for the pregnant person as well as the baby. 
General anesthesia means that you will be unconscious and feel nothing
during the birth. 
These medications are usually given through an intravenous tube (IV) and/or
inhaled through a mask. This type of anesthesia requires a breathing tube to
be inserted into the lungs. Pain control is achieved immediately.
LABOR + CHILDBIRTH
GENERAL ANESTHESIA 
PROS  CONS  
patients experience no pain
works immediately
passes to baby
sore throat from breathing tube




Local anesthesia means that just one part of the body is numb. This is
achieved by injecting medicine into or near the desired area. This can be
used during or immediately after labor to numb the vagina, vulva (vaginal
opening), or perineum (the area between the vulva and anus).
PROS  CONS  
no opioid medication used
works within minutes
minimal risk of side effects
does not numb uterine
contractions
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This is a form of local anesthesia. It is accomplished by injecting medication
into the vaginal wall. It is useful right before birth, if forceps or a vacuum
extractor is used, or right after birth during stitching of a tear or episiotomy. 
It numbs the perineum between the vulva and anus. Pain relief is achieved
within a few minutes and lasts about an hour.
LABOR + CHILDBIRTH
PUDENDAL
PROS  CONS  
OPIOIDS  
Injected opioids (hydromorphone, morphine, fentanyl) do not have the same
numbing effect as the interventions listed above, but are very effective pain
killers.
Depending on the medication used, they kick in within a few minutes and last
from about 30 minutes to 3 hours. They should only be used early in labor
because they pass to the baby and can cause sedation after birth.
PROS  CONS  
works quickly
has a calming effect
causes sedation
passes to baby
does not fully block pain 
does not numb uterine
contractions
sometimes it only works on one
side
no opioid medication used
works within minutes
minimal risk of side effects
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LABOR + CHILDBIRTH
MEDICATION-INDUCED NAUSEA
Most people will not have side effects from anesthesia, but some may
experience nausea and vomiting. 
Higher doses, such as those used in general or spinal anesthesia for a 
cesarean section, may come with higher risk of post-operative nausea. 
Vomiting after birth, especially a cesarean section, can be extremely painful
and cause increased pain medication requirements. 
There may not be a way to eliminate nausea, but the following interventions
can help:
aromatherapy with mint, lemon, or ginger
cool wet cloth on face and neck
mint or ginger tea 
Avoid looking at things close to the face for prolonged periods of
time. This can cause dizziness.
When nursing or holding the baby, be sure to look up for a few
seconds every few minutes.
Brace incision with a pillow and/ or abdominal binder during
vomiting to decrease pain. 
Rinse mouth or wipe with oral swabs after vomiting. Ask provider
for oral swabs (aka toothettes) if available. Oral swabs can be
purchased at drugstores.
Check with provider to be sure consumption of clear liquids is allowed.
mint chewing gum 
Check with provider. Do not use until sedation is worn off to avoid choking.
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Complementary and Alternative Medicine Interventions (CAM) can be very
helpful for patients who desire to use them - but are not likely to be
sufficient for surgical or complicated birth. 
If you plan to use only CAM for pain relief, it is important that you be
flexible and acknowledge that the birthing process is unpredictable. 
Nitrous oxide is inhaled through a mask that the laboring person holds in
their hand and only breathes from when needed. Despite the name, it will not
make patients laugh, but can make them feel a little silly for a few seconds.
Nitrous oxide just takes the edge off and does not block pain or cause sedation.  
It works within seconds and wears off within seconds. 
LABOR + CHILDBIRTH
NITROUS OXIDE 
PROS  CONS  
COMPLEMENTARY + ALTERNATIVE MEDICINE 
INTERVENTIONS  
does not fully block painvery short-acting
does not cause sedation
(N  O, laughing gas)2 
ACUPRESSURE 
Some people find relief if pressure is applied to certain pressure points.
Common points for labor pain are the forehead between the eyes or the
low back just above the pelvis.
Be sure to use a licensed professional if using acupuncture during labor
and clear it with the birth provider in advance. To learn more about
acupressure or acupuncture visit aobta.org
ACUPUNCTURE 
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Perineal massage with water-soluble lubricant during labor probably does not
reduce the risk of tearing, but can feel good. Have someone with clean hands
and short fingernails massage the lower part of the vaginal opening for a
minute or two, then insert their index fingers about an inch into the vagina.
Then they apply gentle pressure down and to the side in a U-shaped motion. 
Reflexology is a technique of pressure applied
with the provider’s fingers to the patient’s feet,




HYPNOSIS + MEDITATION   
PERINEAL MASSAGE    
TENS    (TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION)     
If meditation, mindfulness or hypnosis are a part of your life, you may find it
helpful and centering to use these techniques during labor.
This technique involves electrodes placed on the back connected to a
machine that can be used to deliver small electrical pulses. If clients plan to
use this technique during labor, instruct them to try it out beforehand and get
trained on how to use it by a healthcare provider. 
Do NOT use TENS:
during water birth or in the shower
if it is interfering with fetal monitoring or other equipment
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LABOR + CHILDBIRTH
LOW-TECH INTERVENTIONS
HEAT + ICE 
Heat and ice can be applied to ease
muscle pain, especially in the lower back.
You can also take a warm bath or
shower.
Breathing exercises have been practiced by laboring people for generations
and can help with pain during labor while ensuring that the laboring person
and fetus get enough oxygen. For more information visit www.lamaze.org
BREATHING   
POSITIONING  
Position changes can be helpful for relieving pressure during early labor. It
can be helpful to practice prior to labor onset. You may wish to use a partner
or a birthing ball for support and balance. 




Birth providers will not offer any medication that could be harmful to human
milk or nursing babies, unless the benefit outweighs the risks. You should
always consult your provider before taking any medication or herbal
supplement. More information can be found at National Institutes of Health
database on medications and human milk safety, LactMed
LABOR + CHILDBIRTH
POSTPARTUM PAIN MANAGEMENT
MEDICATIONS   
ACETAMINOPHEN (TYLENOL®)  
This medication can be taken every 4-8 hours after birth, depending on dose
and provider orders. It is administered intravenously (IV) or orally (pills). It is
especially helpful when taken in combination with other medicines.
Know how much acetaminophen you're taking:
Acetaminophen is also in medications such as Norco®, Percocet®, and
Vicodin®. Do not take additional acetaminophen while taking these




These medications can be taken every 6-8 hours after birth, depending on
dose and provider orders. Ketorolac is usually given intravenously (IV), and
ibuprofen is given orally (pills). These medications help reduce or prevent
swelling and inflammation as well as pain.
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These are the most common opioid medications offered to postpartum
patients. They can be taken on a schedule or only as needed, depending on
dose and provider orders. Often, they will be offered as combined pills with
acetaminophen (see box above). They can cause constipation, drowsiness,
and pass into human milk, so doses should be as minimal as possible.
This medication is given intravenously (IV). It is a partial opioid
agonist/antagonist. It can be useful for reducing pain, and reducing opioid-
induced itching and/or nausea. Nalbuphine should NEVER be used for
someone who is physiologically dependent on opioids, because it can
cause immediate withdrawal. 
LABOR + CHILDBIRTH
HYDROCODONE (NORCO®, VICODIN®) AND 




These opioid medications may be used intravenously (IV) or in pill form if
other medications are not sufficient. They are stronger than hydrocodone




These medications may be given with opioids in
order to reduce the required dose.
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For many people who have cesarean sections, pressure from abdominal gas
buildup after delivery can very painful. These medications can make it easier
to pass gas.  See the passing gas section below for more tips.
LABOR + CHILDBIRTH
SIMETHICONE (MYLICON®, GAS-X®)
STOOL SOFTENERS AND LAXATIVES (DOCUSATE, SENNA,
COLACE®, SENOKOT®)
For people who deliver vaginally, having a bowel movement after birth can
be scary and painful. These medications work either by softening the stool or
stimulating the bowel to push out the stool.
BENZOCAINE SPRAY (DERMOPLAST®) 
This medication may be offered as needed. It is an aerosol spray that numbs
an area for about 15 minutes. Some people find it helpful for vaginal pain or
hemorrhoids after delivery, or before having a bowel movement.
WITCH HAZEL PADS (TUCKS®)
Witch hazel is an herb which is thought to help with pain and itching. These
pads can be placed on top of ice packs for vulva application, between the
buttocks for hemorrhoid application, or both. They are available at drugstores.
HYDROCORTISONE CREAM 
This medication can be used to reduce
discomfort and/or shrink hemorrhoids.
Extra strength is available only by
prescription, but 1% hydrocortisone is
available in drugstores.
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There are many actions and products that can help with postpartum pain
when opioids are not prescribed or not an option.  The following
interventions will be arranged by the pain source. 
Ice is one of the most effective methods to ease pain. Crushed ice
can be put inside of a disposable baby diaper or a non-latex glove
wrapped in soft disposable dry wipes and placed in the underwear.
Chemical cold packs attached to absorbent pads are also available.
Support people can ask staff to show them how to make ice packs so
that they are more readily available. Ice should be used for about 20
minutes at a time with breaks in between applications. Ice not only
reduces pain, but also swelling and inflammation.  Request ice packs
from your provider to take home. 
NON-PHARMACOLOGICAL PAIN MANAGEMENT
VAGINA, VULVA,
PERINEUM, ANUS   
Sitting for prolonged periods of time can put pressure on the perineum.
Changing position and frequent walking helps decrease this pressure.
After delivery, it is safe to sleep in any comfortable position.
LABOR + CHILDBIRTH
ICE OR COLD PACKS
CHANGING POSITION
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These items are available at drugstores or from
some hospitals. They are used to run warm water
or prescribed medications over the vulva. 
This is a more comfortable method of cleansing
than wiping with toilet paper. The same effects
can be accomplished with a removable shower
head and a shower chair. 
Be sure that water temperature is comfortable and
not too hot.
To help decrease hemorrhoid pain with bowel movements,
eat foods that soften stools:
berries
apples




HIGH FIBER DIET  
SITZ BATH OR PERINEAL CARE BOTTLE (“PERI” BOTTLE)
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Ice or chemical cold packs can be applied to the incision for about
20 minutes at a time with breaks between applications.
LABOR + CHILDBIRTH
ICE 
CESAREAN SECTION INCISION PAIN
BRACING WITH PILLOW 
Laughing, vomiting, sneezing, and coughing can cause incision
pain. It can help to brace the incision with a pillow before any of
these actions.
ABDOMINAL BINDER 
Abdominal binders should be worn snugly and to
comfort. They do not help with losing weight or
shrinking the stomach after birth. It is possible
that they protect the incision, but their main
purpose is to decrease pain.
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Uterine cramping continues for several days to weeks after
birth as the uterus shrinks back down to its usual size.
They are usually only bothersome for a few days, and then
barely noticeable. These cramps increase in intensity with
each birth, so the cramps following your fifth birth will be
more intense than those following your first. Cramps are
more intense during activities that release natural oxytocin,
such as breast/chestfeeding, cuddling your baby, or
hearing them cry. It helps to anticipate these times and use
measures to decrease this pain before it starts.
ABDOMINAL PRESSURE AND UTERINE CRAMPS
walk frequently
decide not to be embarrassed about passing gas
ask for privacy or pass gas in a warm/hot shower
minimize opioid pain medications
avoid foods that cause gas, like fried food, beans, dairy, etc.
HEAT
Heat can relax muscles and ease cramping pain. Ask for a warm blanket or
heating pad to place on the abdomen. This can be used simultaneously with
incision ice if necessary. Remove the heating pad when nursing or holding
the baby, to avoid injury.
Some of the methods of pain control can cause a decrease in passing gas.
This gas can build up and cause intense pain after delivery. Some people
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POSTPARTUM 
The first year after having a baby
is physically and emotionally
difficult. Your body is still re-
adjusting and there can be a lot of
stress in your life. Some people who
stop using drugs during pregnancy
start again after birth, and some find
themselves using more chaotically
after having a baby while dealing
with these changes.
This section will discuss a few of the
things that may come up during the
first year following the birth. This
includes planning to prevent
overdose and finding support for
common mood and anxiety disorders.  
It will also discuss options for








Some people taper off of methadone
or buprenorphine after their
pregnancy because they or their
providers think they no longer need
it. However, this is often dangerous
and increases risks of relapse,
overdose and death.  In one study in
Massachusetts, overdose rates
were highest among people 7-12
months after delivery of a baby.
It can be hard to talk with loved ones
about your substance use, and
sometimes you might feel like you’re
letting people down if you start using
after taking a break. 
Try and find someone you can
trust, a family member or friend, a
counselor or provider, and discuss
a plan for how you can cope with
triggers and stay safe if you use. 
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Some people may be familiar with
the term Postpartum Depression.
For generations, we have
recognized that some people
become depressed after giving
birth. We have realized however,
that the mental health differences
experienced by pregnant and
postpartum people are much more
varied than this. That is why we
now refer to these conditions as
Perinatal Mood and Anxiety
Disorders (PMADs). 
PMADs are fairly common, and can
impact pregnant people and their
partners.  These disorders can be
experienced from the beginning
of pregnancy through the first
year after birth.
In addition, after you deliver your
baby, some of the support you
relied on may change. Because of
insurance, you may lose access to
the treatment team you had during
your pregnancy.  
During the postpartum period, your
tolerance may fluctuate. Remaining
on medications for opioid use
disorder (MOUD)  after your
delivery can help protect you 
PSYCHOSOCIAL SUPPORT AND PERINATAL
MOOD AND ANXIETY DISORDERS (PMADS)
from overdose given these
changes in tolerance.
It is recommended by many
experts to stay on MOUD as long
as you need to stay healthy; some
people stay on it for life. 
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PMADs include depression, anxiety,
and psychosis. People may
experience repetitive or unwelcome
thoughts. For example, an image of
something bad happening to the baby
that comes to mind again and again,
seemingly from an outside source.
This is different from the mild mood
swings experienced by most people
after having a baby, sometimes called
“baby blues.” 
“Baby blues” generally come and go,
but if they last two weeks or more,
talk to a provider. PMADs can be
unrelenting, interfere with self and
baby care, and can be accompanied





  Factors that may increase of PMADs risk are:
  
Personal or family history of
other mental health problems
Experience of trauma/ violence,
especially as relates to previous
pregnancy or sexual abuse
Current or past substance use
Post Traumatic Stress Disorder
(PTSD)
Poverty
Isolation   
Ask yourself these questions:
 How are you feeling? 
 Are you having thoughts of hurting yourself or your children, even if you 
 don’t want to? 
 Crying or on the verge of tears all day? 
 Do you feel guilty, hopeless, angry, numb, or worthless? 
Talk with your healthcare provider about how you’re feeling and if you’d like a
referral to mental health support. You should tell someone right away if you
have thoughts of hurting yourself or someone else.
  
New York State 24-hour free help-line:
Postpartum Support International 
24-hour hotline:
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Suicide Prevention Lifeline: 
Parental Stress Hotline –
Help for Parents: 
Crisis Text Line: 
EMERGENCY RESOURCES:HELPLINES:
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MORE INFORMATION:
1-800-273-TALK (8255)
1-800-632-8188      









Many people may not realize it is
possible to become pregnant in the
year after having a baby.  Some people
may want to avoid this because they do
not want to have another baby right
now, while others may be excited at the
prospect of having a large family with
children close in age. There are many
options to consider around when and
what kind of contraception to use if you
do not want to have another pregnancy
within the next year.  






There are many kinds (such as the IUD,
oral contraception pills, patches, rings, or
injections) and they all have their own
benefits. Some you may take daily, such
as the pill, and others can last for
months or years (injections, IUDs,
implant). You can ask your medical
provider for one of these forms of birth
control before leaving the hospital, or get
it at a doctor’s visit later.  You should
discuss with your doctor if you have any
concerns such as heavy period, cramping,
weight issues, etc.  Your provider should
never try and influence your decision or
push you towards a method that you
are not interested in. 
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It is important to understand that the origins of gynecology and obstetrics are tied to
racism and the abuse of Black and Brown birthing people. As medicine has become
established, and birth more medicalized, this history has been deeply embedded in
the process. Many Black and Latinx people experienced reproductive coercion and
violence, and the movement around contraceptive services has often been exploited
by those with xenophobic and racist ideologies. One example of this is the human
trials of the oral contraceptive pill conducted in Puerto Rico on poor women of color
in 1956.  These trials did not have informed consent and the researchers were later
denounced for colonialism, racism and unethical research practices.   In another
case, 148 people incarcerated in California Women's prisons were sterilized without
their consent between 2006-2010.    
Family Planning Benefit Program(NY.GOV)
Free Services for NYS Residents
(Panned Parenthood)
Like all of the decisions outlined in this toolkit, the decision to breast/chestfeed,
use formula, or both, is very personal.  This section discusses how different
substances affect lactation and human milk.  You can find more detailed
information on medications and their safety during pregnancy and lactation
at LactMed.  If you want information on how these substances also impact fetal
development and how to prevent some common harms, see Section 2: Harm
Reduction.  If you read Section 2, this information on lactation will be familiar.   
BREAST/CHESTFEEDING AND HUMAN MILK
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Drug Use and Human Mi lk:  
Legal and Chi ld Welfare Considerat ions
"We believe that breast/chest feeding families who use
substances are best served by evidence-based and harm
reduction practices provided through the healthcare
system, not the legal or child welfare system."
  
ALCOHOL
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Alcohol passes into human milk and is absorbed by babies.   
If you have plans that may include alcohol consumption, pump and store
enough milk beforehand to feed the baby, or plan to use formula. 
While drinking/intoxicated, and your breasts/chest become painful, pump or
hand express enough milk to relieve the pressure and discard it. You do not
need to fully empty, because the body continually filters alcohol out of milk,
just like it does with blood, so when you sober up, the milk does too. 
Recommendations for the time it takes for your milk to be safe for the baby
range from 2-4 hours per drink.    If you are only going to have one standard
drink, it is okay to feed the baby, have a drink, wait a few hours, and feed the
baby again without doing anything special.  
If you stil l feel drunk or hungover, even if the recommended time has passed,
wait until you feel better before providing milk to the baby. If you want to




It is safe to breast/chestfeed while taking medications for opioid use
disorder such as methadone and buprenorphine, regardless of the dose
of medication that you take. In fact, it can actually make the baby’s
withdrawal less severe. Studies suggest this is because skin-to-skin
contact and attachment formation help the baby feel better while
breast/chestfeeding.        
With heroin, it is best not to breast/chestfeed, since we can’t know the
exact dose and it may be cut with other unknown substances and
contaminants that aren’t safe for the baby.  When we study other opioids
like methadone, we find that only about 2% of the total dose makes it into
human milk.   For buprenorphine, there are negligible amounts of
buprenorphine/norbuprenorphine in human milk and infants absorb even
less of this because of the way buprenorphine is broken down and













Formal guidelines recommend that the safest choice is to stop
recreational use completely while lactating.
If you continue using while breast/chestfeeding, consider using harm
reduction methods like pumping before using or pumping and dumping
right after using. It’s important to remember that even though there are
risks from smoking and breast/chestfeeding, it is still considered better
to breast/chestfeed and smoke than to formula feed and smoke.
It is important to take as low a dose of benzodiazepines as possible if
breast/chestfeeding. Not all benzodiazepines are the same in regard
to safety and breast/chestfeeding (lorazepam is safer than diazepam,
for example). Talk to your doctor about which medication you take and
at what dose. 
In small studies, some babies have low muscle tone, sedation and/or
difficulties breathing at delivery and also at breast/chestfeeding.  One
problem with many of these studies is that because they have a small
number of participants, their findings can be difficult to generalize. 
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Smoking may decrease the amount of milk produced, and/or cause the
milk to dry up earlier. Nicotine and other harmful substances in cigarettes
can pass to the baby from human milk.     It’s important to remember that
even though there are risks from smoking and breast/chestfeeding, it is
stil l considered better to breast/chestfeed and smoke than to formula
feed and smoke. 
Children that are exposed to second-hand or third-hand smoke (residue
left on clothes or surfaces in the home) can have increased risk of ear
infections, coughs, colds, breathing problems (asthma, bronchitis and
pneumonia), tooth decay and ongoing exposure to cancer-forming
chemicals formed by cigarette smoke or vapes.   Children with this
exposure could grow up to have increased risk of cataracts, heart and






Stimulants pass into human milk, and can decrease the amount of milk
produced, and/or cause the milk to dry up earlier.         Up to 200mg of
caffeine per day is considered safe (one 8-oz cup of coffee contains 90-
100mg caffeine, on average).        It is recommended to discard milk for
24 hours after cocaine use, and 48 hours after methamphetamine use
(during this time, continue to pump or express milk so that your supply
does not decrease). 
Both cocaine and methamphetamine are excreted in the human milk and
there have been reports of severe infant effects from cocaine overdose,
and one death after methamphetamine exposure via human milk.      In
some states, new parents have been convicted of child endangerment or
even manslaughter if the infant death was related to breast/chestfeeding
and substance use.    
STIMULANTS
16, 17, 19
12, 18, 19 
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Thanks for reading this toolkit.  As we
mentioned in the introduction, all
content found in this toolkit, including:
text, images, and other formats were
created for informational purposes
only.
This content is not intended to be a
substitute for professional medical or
legal advice, diagnosis, or treatment.
Always seek the advice of your
physician or other qualified health
provider or legal counsel with any
questions you may have regarding a
medical condition or legal situation.
Never disregard professional medical
advice or delay in seeking it because




We'd like to give a special things to Dr.
Mishka Terplan, Dr. Tricia Wright, Lynn
Paltrow, and Indra Lusero of National
Advocates for Pregnant Women, as well as
The Bronx Defenders Family Defense
Practice, and Movement for Family Power
for your support on this toolkit.  
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We now that you are the experts.
We would love to hear from you. Can
this toolkit be improved? Do you want
to be involved in future work?
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